RPXD002

N/A

Report date: 2023/04/14 10:45:26
NME

Base Information

Drug NameRPXD002
Drug Alias NameRPXD002RPXD-002
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsMetabolic Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesRuipuxin(Suzhou)Bio-Medical Technology Co LtdNational Institute Of Biological Sciences, Beijing
China Registration ClassN/A

Develop Information

Active CompaniesNational Institute Of Biological Sciences, BeijingRuipuxin(Suzhou)Bio-Medical Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsMetabolic Syndrome
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A